Form 4 for AMPH Amphastar Pharmaceuticals, Inc.
Accepted 2022-02-09 00:00:00 ET · period of report 2022-02-08 · accession 0001104659-22-017336 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-09 | 2022-02-08 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas | M - OptEx | $14.95 | +10.0K | 116.0K | +9% | +$149.5K |
| D | 2022-02-09 | 2022-02-08 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas | S - Sale+OE | $26.95 | -10.0K | 106.0K | -9% | -$269.5K |
| D | 2022-02-09 | 2022-02-08 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas | M - OptEx | $0.00 | -10.0K | 48.1K | -17% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-08 | M | A | 10,000 | $14.95 | 116,042 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-08 | S | D | 10,000 | $26.95 | 106,042 | D | — | — | |
| 3 | Derivative | Employee Stock Option (right to buy) | 2022-02-08 | M | D | 10,000 | $0.00 | 48,074 | D | $14.95 · — to 2025-03-26 | 10,000 Common Stock | (F2) Shares subject to the option are fully vested and immediately exercisable. |